[1]
P. Kaur, D. D. Bhandari, and H. Chopra, “Streptomyces-Derived Nano-Doxorubicin: Clinical Status and Patents Granted”, Scr Med, vol. 55, no. 6, pp. 773–784, Dec. 2024, doi: 10.5937/scriptamed55-52207.